...
首页> 外文期刊>Toxins >Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein
【24h】

Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein

机译:Trichosanthin,1型核糖体灭活蛋白的结构和功能性研究和药理机制

获取原文
           

摘要

Trichosanthin (TCS) is an RNA N -glycosidase that depurinates adenine-4324 in the conserved α-sarcin/ricin loop (α-SRL) of rat 28 S ribosomal RNA (rRNA). TCS has only one chain, and is classified as type 1 ribosome-inactivating protein (RIP). Our structural studies revealed that TCS consists of two domains, with five conserved catalytic residues Tyr70, Tyr111, Glu160, Arg163 and Phe192 at the active cleft formed between them. We also found that the structural requirements of TCS to interact with the ribosomal stalk protein P2 C-terminal tail. The structural analyses suggest TCS attacks ribosomes by first binding to the C-terminal domain of ribosomal P protein. TCS exhibits a broad spectrum of biological and pharmacological activities including anti-tumor, anti-virus, and immune regulatory activities. This review summarizes an updated knowledge in the structural and functional studies and the mechanism of its multiple pharmacological effects.
机译:Trichosanthin(TCS)是RNA N-糖苷酶,其在大鼠28 S核糖体RNA(RRNA)的保守α-Sarcin / Ricin环(α-SRL)中脱染腺嘌呤-4324。 TCS只有一根链,并被分类为1型核糖体灭活蛋白(RIP)。我们的结构研究表明,TCS由两个结构域组成,其中五个保守的催化残基Tyr70,Tyr111,Glu160,Arg163和PHE192在它们之间形成的活性裂隙。我们还发现,TCS的结构要求与核糖体茎蛋白P2 C末端尾部相互作用。结构分析表明TCS通过首先与核糖体P蛋白的C末端结构域结合来攻击核糖体。 TCS表现出广谱的生物和药理活动,包括抗肿瘤,抗病毒和免疫调节活动。本综述总结了结构和功能研究中的更新知识以及其多种药理效应的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号